Innovations in biomarker detection and personalized medicine for prostate cancer

FHS
August 23, 2024
11:41 pm

In a recent comprehensive review published in Cyborg Bionic Systems, researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application of biomarkers for prostate cancer (PCa).

Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th | Psychedelic Invest

Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to

October 5, 2023

J&J’s new partnership with Elektrofi; Enyo raises €39M; Arrowhead’s $450M offering

Plus, news about TC BioPharm, BioCentriq, 4D Molecular and Arbor Biotechnologies, and Longboard Pharmaceuticals: Johnson & Johnson teams up with Elektrofi: The Boston biotech will

January 4, 2024

Study introduces a novel approach to mapping protein-receptor interactions

One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells.

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.